BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 9787135)

  • 1. The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts.
    Chesi M; Nardini E; Lim RS; Smith KD; Kuehl WM; Bergsagel PL
    Blood; 1998 Nov; 92(9):3025-34. PubMed ID: 9787135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A molecular study of the t(4;14) in multiple myeloma.
    Sibley K; Fenton JA; Dring AM; Ashcroft AJ; Rawstron AC; Morgan GJ
    Br J Haematol; 2002 Aug; 118(2):514-20. PubMed ID: 12139740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ectopic expression of fibroblast growth factor receptor 3 promotes myeloma cell proliferation and prevents apoptosis.
    Plowright EE; Li Z; Bergsagel PL; Chesi M; Barber DL; Branch DR; Hawley RG; Stewart AK
    Blood; 2000 Feb; 95(3):992-8. PubMed ID: 10648414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A global expression-based analysis of the consequences of the t(4;14) translocation in myeloma.
    Dring AM; Davies FE; Fenton JA; Roddam PL; Scott K; Gonzalez D; Rollinson S; Rawstron AC; Rees-Unwin KS; Li C; Munshi NC; Anderson KC; Morgan GJ
    Clin Cancer Res; 2004 Sep; 10(17):5692-701. PubMed ID: 15355895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression.
    Keats JJ; Reiman T; Maxwell CA; Taylor BJ; Larratt LM; Mant MJ; Belch AR; Pilarski LM
    Blood; 2003 Feb; 101(4):1520-9. PubMed ID: 12393535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A subset of multiple myeloma harboring the t(4;14)(p16;q32) translocation lacks FGFR3 expression but maintains an IGH/MMSET fusion transcript.
    Santra M; Zhan F; Tian E; Barlogie B; Shaughnessy J
    Blood; 2003 Mar; 101(6):2374-6. PubMed ID: 12433679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses.
    Fabris S; Agnelli L; Mattioli M; Baldini L; Ronchetti D; Morabito F; Verdelli D; Nobili L; Intini D; Callea V; Stelitano C; Lombardi L; Neri A
    Genes Chromosomes Cancer; 2005 Feb; 42(2):117-27. PubMed ID: 15543617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patients.
    Keats JJ; Maxwell CA; Taylor BJ; Hendzel MJ; Chesi M; Bergsagel PL; Larratt LM; Mant MJ; Reiman T; Belch AR; Pilarski LM
    Blood; 2005 May; 105(10):4060-9. PubMed ID: 15677557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of fibroblast growth factor and FGF-receptor family genes in human myeloma cells, including lines possessing t(4;14)(q16.3;q32. 3) and FGFR3 translocation.
    Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Nakazawa N; Taniwaki M; Yawata Y; Ueki A
    Int J Oncol; 1999 Dec; 15(6):1205-12. PubMed ID: 10568829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3.
    Chesi M; Nardini E; Brents LA; Schröck E; Ried T; Kuehl WM; Bergsagel PL
    Nat Genet; 1997 Jul; 16(3):260-4. PubMed ID: 9207791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of t(4;14)(p16.3;q32) chromosomal translocation in multiple myeloma by double-color fluorescent in situ hybridization.
    Finelli P; Fabris S; Zagano S; Baldini L; Intini D; Nobili L; Lombardi L; Maiolo AT; Neri A
    Blood; 1999 Jul; 94(2):724-32. PubMed ID: 10397739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of IgH-MMSET fusion gene in multiple myeloma patients and its significance].
    Jiang H; Hou J; Chen YB; Ding SQ
    Zhonghua Xue Ye Xue Za Zhi; 2003 Oct; 24(10):515-8. PubMed ID: 14690579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGFR3 dysregulation in multiple myeloma: frequency and prognostic relevance.
    Rasmussen T; Hudlebusch HR; Knudsen LM; Johnsen HE
    Br J Haematol; 2002 Jun; 117(3):626-8. PubMed ID: 12028033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGFR3 gene mutations associated with human skeletal disorders occur rarely in multiple myeloma.
    Fracchiolla NS; Luminari S; Baldini L; Lombardi L; Maiolo AT; Neri A
    Blood; 1998 Oct; 92(8):2987-9. PubMed ID: 9763594
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection of t(4;14)(p16.3;q32) chromosomal translocation in multiple myeloma by reverse transcription-polymerase chain reaction analysis of IGH-MMSET fusion transcripts.
    Malgeri U; Baldini L; Perfetti V; Fabris S; Vignarelli MC; Colombo G; Lotti V; Compasso S; Bogni S; Lombardi L; Maiolo AT; Neri A
    Cancer Res; 2000 Aug; 60(15):4058-61. PubMed ID: 10945609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translocation T(4;14)(p16.3;q32) is a recurrent genetic lesion in primary amyloidosis.
    Perfetti V; Coluccia AM; Intini D; Malgeri U; Vignarelli MC; Casarini S; Merlini G; Neri A
    Am J Pathol; 2001 May; 158(5):1599-603. PubMed ID: 11337357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel IGH-MMSET fusion transcript in a human myeloma cell line with the t(4;14)(p16.3;q32) chromosomal translocation.
    Intini D; Fabris S; Storlazzi T; Otsuki T; Ciceri G; Verdelli D; Lombardi L; Rocchi M; Neri A
    Br J Haematol; 2004 Aug; 126(3):437-9. PubMed ID: 15257719
    [No Abstract]   [Full Text] [Related]  

  • 18. The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity.
    Lauring J; Abukhdeir AM; Konishi H; Garay JP; Gustin JP; Wang Q; Arceci RJ; Matsui W; Park BH
    Blood; 2008 Jan; 111(2):856-64. PubMed ID: 17942756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma.
    Stec I; Wright TJ; van Ommen GJ; de Boer PA; van Haeringen A; Moorman AF; Altherr MR; den Dunnen JT
    Hum Mol Genet; 1998 Jul; 7(7):1071-82. PubMed ID: 9618163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMSET: role and therapeutic opportunities in multiple myeloma.
    Xie Z; Chng WJ
    Biomed Res Int; 2014; 2014():636514. PubMed ID: 25093175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.